Skip to main content
SpringerLink
Log in

The Role of Dexmedetomidine in Intensive Care

  • Conference paper
Intensive Care Medicine

Abstract

The US Food and Drug Administration (FDA) first approved dexmedetomidine in December 1999 for use as a continuous infusion in post-operative ventilated patients for up to 24 hours in the intensive care unit (ICU). It is not yet approved in the European Union. Its use is currently being evaluated in a number of different situations: Longer-term use, perioperative care, anesthesia, and postoperative analgesia. This chapter will focus on its potential for intensive care patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bhana N, Goa KL, McClellan KJ (2000) Dexmedetomidine. Drugs 59: 263–268

    Article  CAS  PubMed  Google Scholar 

  2. Savola J-M, Virtanen R (1991) Central alpha2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. Eur J Pharmacol 195: 193–199

    Article  CAS  PubMed  Google Scholar 

  3. Szumita PM, Baroletti SA, Anger KE, Wechsler ME (2007) Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 64: 37–44

    Article  CAS  PubMed  Google Scholar 

  4. Kamibayashi T, Maze M (2000) Clinical uses of alpha2-adrenergic agonists. Anesthesiology 93: 1345–1349

    Article  CAS  PubMed  Google Scholar 

  5. MacMillan LB, Hein L, Smith MS, et al (1996) Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 273: 801–803

    Article  CAS  PubMed  Google Scholar 

  6. Venn RM, Karol MD, Grounds RM (2002) Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 88: 669–675

    Article  CAS  PubMed  Google Scholar 

  7. Maze M, Scarfini C, Cavaliere F (2001) New agents for sedation in the intensive care unit. Crit Care Clin 17: 881–897

    Article  CAS  PubMed  Google Scholar 

  8. Product information Precedex® (dexmedetomidine). Available at: http://precedex.hospira.com/_docs/PrecedexPI.pdf Accessed Nov 2008

    Google Scholar 

  9. Venn RM, Newmann PJ, Grounds RM (2003) A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 29: 201–207

    CAS  PubMed  Google Scholar 

  10. Martin E, Ramsay G, Mantz J, Sum-Ping ST (2003) The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 18: 29–41

    Article  PubMed  Google Scholar 

  11. Bachand R, Scholz J, Pinaud M, et al (1999) The effects of dexmedetomidine in patients in the intensive care setting. Intensive Care Med 25 (Suppl 1): S160 (abst)

    Google Scholar 

  12. Martin E, Lehott JJ, Manikis P, Torres L, Cote D, Mooi B (1999) Dexmedetomidine: a novel agent for patients in the intensive care setting. Intensive Care Med 25 (Suppl 1): S160 (abst)

    Google Scholar 

  13. Riker RR, Ramsay MAE, Prielipp RA, Jorden VSB (2001) Dexmedetomidine provides effective long-term sedation for intubated ICU patients compared to midazolam: a randomized open-label pilot study. Chest 120: 260s (abst)

    Google Scholar 

  14. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M (2004) Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 30: 2188–2196

    Article  PubMed  Google Scholar 

  15. Richard R, Riker RR, Fraser GL (2005) Adverse events associated with sedatives, analgesics and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy 25: 8S–18S

    Article  Google Scholar 

  16. Venn RM, Grounds RM (2001) Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 87: 684–690

    Article  CAS  PubMed  Google Scholar 

  17. Triltsch AE, Welte M, Von Homeyer P, et al (2002) Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med 30: 1007–1014

    Article  CAS  PubMed  Google Scholar 

  18. Dasta JF, Kane-Gill SL, Durtschi AJ (2004) Comparing dexmedetomidineprescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 38: 1130–1135

    Article  CAS  PubMed  Google Scholar 

  19. Chrysostomou C, Schmitt C (2008) Dexmedetimidine: sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol 4: 619–627

    Article  CAS  PubMed  Google Scholar 

  20. Venn RM, Bradshaw CJ, Spencer R, et al (1999) Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 54: 1136–1142

    Article  CAS  PubMed  Google Scholar 

  21. Herr DL, Sum-Ping ST, England M (2003) ICU sedation after coronary artery bypass surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothor Vasc Anesth 17: 576–584

    Article  Google Scholar 

  22. Ickeringill M, Shehabi Y, Adamson H, Ruettimann U (2004) Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy. Anaesth Intensive Care 32: 741–745

    CAS  PubMed  Google Scholar 

  23. Venn RM, Hell J (2004) Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4: 302–308

    Article  Google Scholar 

  24. Corbett SM, Rebuck JA, Greene CM, et al (2005) Dexmedetomidine does not improve patient satisfaction when compared to propofol during mechanical ventilation. Crit Care Med 33: 940–945

    Article  CAS  PubMed  Google Scholar 

  25. Elbaradie S, El Mahalawy FH, Solyman AH (2004) Dexmedetomidine vs propofol for short-term sedation of postoperative mechanically ventilated patients. J Egyptian Nat Cancer Inst 16: 153–158

    Google Scholar 

  26. MacLaren R, Forrest LK, Kiser TH (2007) Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy 27: 351–359

    Article  CAS  PubMed  Google Scholar 

  27. Arain Sr, Ruehlow RM, Uhrich TD, et al (2004) The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 98: 153–158

    Article  CAS  PubMed  Google Scholar 

  28. Hsu YW, Cortinez LI, Robertson KM, et al (2004) Dexmedetomidine pharmacodynamics. Part 1: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 101: 1066–1076

    Article  CAS  PubMed  Google Scholar 

  29. Ely EW, Shintani A, Truman B, et al (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291: 1753–1762

    Article  CAS  PubMed  Google Scholar 

  30. Maldonado JR, Wysong A, Van Der Starre PJ, et al (2005) Alpha-2 agonist induced sedation prevents ICU delirium in post-cardiotomy patients. J Psychosom Res 58: 61 (abst)

    Article  Google Scholar 

  31. Pandharipande PP, Pun BT, Herr DL, Maze M (2007) Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients. JAMA 298: 2644–2653

    Article  CAS  PubMed  Google Scholar 

  32. Siobal MS, Kallet RH, Kivett VA, Tang JF (2006) Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: a pilot study. Respir Care 51: 492–496

    PubMed  Google Scholar 

  33. Baddigam K, Russo P, Russo J, Tobias JD (2005) Dexmedetomidine in the treatment of with-drawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 20: 118–123

    Article  PubMed  Google Scholar 

  34. Maccioli GA (2003) Dexmedetomidine to facilitate drug withdrawal. Anesthesiology 98: 575–577

    Article  PubMed  Google Scholar 

  35. Multz AS (2003) Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 96: 1054–1055

    Article  PubMed  Google Scholar 

  36. Doufas AG, Lin CM, Suleman MI, et al (2003) Dexmedetomidine and meperidine additively reduce the shivering threshold in humans. Stroke 34: 1218–1223

    Article  CAS  PubMed  Google Scholar 

  37. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD (2000) The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93: 382–394

    Article  CAS  PubMed  Google Scholar 

  38. Paris A, Tonner PH (2005) Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 18: 412–418

    Article  PubMed  Google Scholar 

  39. Ingersoll-Weng E, Manecke GR Jr, Thistlethwaite PA (2004) Dexmedetomidine and cardiac arrest. Anesthesiology 100: 738–739

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, St George’s Hospital, Blackshaw Road, London, SW17 0QT, UK

    R. Rahman West & A. Rhodes

  2. Department of Anesthesiology and Intensive Care, Friedrich-Schiller-University, Erlanger Allee 101, 07743, Jena, Germany

    R. M. Grounds

Authors
  1. R. Rahman West
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Rhodes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. M. Grounds
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Universitée libre de Bruxelles, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Rahman West, R., Rhodes, A., Grounds, R.M. (2009). The Role of Dexmedetomidine in Intensive Care. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92278-2_81

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-92278-2_81

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-92277-5

  • Online ISBN: 978-0-387-92278-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation